Hou et al.23 showed that in MDS patients with U2AF1 mutation, those with RUNX1 mutation were independent adverse factors affecting hematopoietic stem cell transplantation, suggesting that the type of co-mutation gene may have an impact on prognosis. The gene discussed is RUNX1; the disease is myelodysplastic syndrome.